Change in the number of votes relating to Biotie Therapies Corp.'s shares
BIOTIE THERAPIES CORP. Stock Exchange Release 21 August 2014 at 10.05 am
Change in the number of votes relating to Biotie Therapies Corp.'s shares
Biotie Therapies Corp. ("Biotie" or the "Company") has conveyed Biotie shares held as treasury shares, that were issued on 2 January 2014, pursuant to the Stock Option Plan 2011 and the Equity Incentive Plan 2011 (the "Plans") as follows:
Shares conveyed |
Cumulative shares conveyed since 2 January 2014 |
Remaining shares to be conveyed |
247,500 | 3,306,660 | 15,000 |
Under the Stock Option Plan 2011, the owners of the stock options may subscribe for a maximum total of 7,401,000 new shares in the Company or existing shares held by the Company. A total of 247,500 shares have been subscribed for during the period 30 July 2014 and 20 August 2014 and 247,500 of the treasury shares will be used for these share subscriptions. The subscription price of EUR 0.01 per share has been fully paid by the employee and the EUR 2,475 funds received will be credited to the Company's reserve for non-restricted equity.
Based on the Equity Incentive Plan 2011 no shares have been conveyed during the period 30 July 2014 and 20 August 2014.
The conveyed shares previously held as treasury shares have not carried any voting rights. The conveyance does not affect the number of registered shares. After the conveyances the changes are as follows:
Increase in number of outstanding shares |
Total amount of voting rights |
Number of the Company's share held by the Group |
Total number of registered shares |
247,500 | 450,681,015 | 5,351,383 | 456,032,398 |
Turku, 21 August 2014
Lesen Sie auch
Biotie Therapies Corp.
Timo Veromaa, President and CEO
For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com
www.biotie.com
DISTRIBUTION:
NASDAQ OMX Helsinki Ltd
Main Media
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Biotie Therapies Oyj via Globenewswire